Inactive Instrument

Analyst Reco. Convey Health Solutions Holdings, Inc.

Equities

Guggenheim Downgrades Convey Health Solutions Holdings to Neutral From Buy	22-06-22	MT
Barclays Downgrades Convey Health Solutions Holdings to Equalweight From Overweight, Adjusts Price Target to $11 From $12	22-06-22	MT
Guggenheim Starts Convey Health Solutions Holdings at Buy With $12 Price Target	22-04-07	MT
Goldman Sachs Adjusts Convey Health Solutions Holdings' Price Target to $9 from $10, Keeps Neutral Rating	22-03-24	MT
Canaccord Genuity Cuts Price Target on Convey Health Solutions Holdings to $14 From $18; Buy Rating Kept	22-03-24	MT
Goldman Sachs Initiates Convey Health Solutions at Neutral, Sets Price Target at $10	22-02-11	MT
Barclays Adjusts Price Target on Convey Health Solutions Holdings to $12 From $16, Reiterates Overweight Rating	22-02-07	MT
CONVEY PARENT : Truist Securities Starts Convey Holding Parent at Buy With $16 Price Target	21-07-12	MT
CONVEY PARENT : Canaccord Genuity Starts Convey Holding Parent at Buy With $18 Price Target	21-07-12	MT
CONVEY PARENT : JPMorgan Starts Convey Holding Parent at Neutral With $12 Price Target	21-07-12	MT
CONVEY PARENT : BofA Securities Starts Convey Holding Parent at Buy With $15 Price Target	21-07-12	MT
CONVEY PARENT : Goldman Sachs Starts Convey Holding Parent at Buy With $21 Price Target	21-07-12	MT
CONVEY PARENT : Barclays Starts Convey Holding Parent at Overweight With $16 Price Target	21-07-12	MT

No results for this search